OpenAI acquires Orchestra Bio
OpenAIen
OpenAI
AI Global WireOpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
This is a short summary published by AI Global Wire. The full article is owned and hosted by OpenAI — open it there to read it in full.
Read the full story at OpenAI- OpenAI
Related AI news
- OpenAI CEO Sam Altman wins dismissal of sister's lawsuitBBC Technology · October 20, 2026
- Deepseek open-sources the inference engine that powers its fastest and cheapest AI modelThe Decoder · October 20, 2026
- ChatGPT now lets you lock your chatsTechCrunch AI · October 20, 2026
- A US judge dismisses a civil sexual abuse lawsuit brought against Sam Altman by his sister, after she refused to appear for an independent medical examination (Luc Cohen/Reuters)Techmeme · October 20, 2026
- OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind (Madison Mills/Axios)Techmeme · October 20, 2026
- Exclusive: OpenAI has acquired Orchestra BioAxios · October 20, 2026